CA2338861A1 - Pansement contenant de l'estradiol pour l'application transdermique d'hormones - Google Patents

Pansement contenant de l'estradiol pour l'application transdermique d'hormones Download PDF

Info

Publication number
CA2338861A1
CA2338861A1 CA002338861A CA2338861A CA2338861A1 CA 2338861 A1 CA2338861 A1 CA 2338861A1 CA 002338861 A CA002338861 A CA 002338861A CA 2338861 A CA2338861 A CA 2338861A CA 2338861 A1 CA2338861 A1 CA 2338861A1
Authority
CA
Canada
Prior art keywords
active substance
containing patch
pressure
patch according
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002338861A
Other languages
English (en)
Inventor
Elvira Kirstgen
Reinhold Meconi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2338861A1 publication Critical patent/CA2338861A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/58Adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

L'invention concerne un pansement contenant des principes actifs et permettant l'apport contrôlé d'estradiol ou de ses dérivés pharmaceutiquement compatibles, seuls ou en association avec des progestatifs, à la peau humaine ou animale. Ce pansement comporte une couche envers à laquelle est relié un réservoir de principes actifs approprié pour l'apport combiné de principes actifs et réalisé à l'aide d'adhésif, et une couche protectrice redécollable. Ce pansement est caractérisé en ce que l'adhésif contient du cholestérol ou de l'amidon de maïs.
CA002338861A 1998-07-29 1999-07-16 Pansement contenant de l'estradiol pour l'application transdermique d'hormones Abandoned CA2338861A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19834006A DE19834006A1 (de) 1998-07-29 1998-07-29 Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
DE19834006.0 1998-07-29
PCT/EP1999/005084 WO2000006130A1 (fr) 1998-07-29 1999-07-16 Pansement contenant de l'estradiol pour l'application transdermique d'hormones

Publications (1)

Publication Number Publication Date
CA2338861A1 true CA2338861A1 (fr) 2000-02-10

Family

ID=7875612

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002338861A Abandoned CA2338861A1 (fr) 1998-07-29 1999-07-16 Pansement contenant de l'estradiol pour l'application transdermique d'hormones

Country Status (14)

Country Link
EP (1) EP1100478A1 (fr)
JP (1) JP2002521426A (fr)
KR (1) KR20010072071A (fr)
CN (1) CN1310615A (fr)
AR (1) AR019948A1 (fr)
AU (1) AU762589B2 (fr)
BR (1) BR9912688A (fr)
CA (1) CA2338861A1 (fr)
DE (1) DE19834006A1 (fr)
IL (1) IL141032A0 (fr)
PL (1) PL345696A1 (fr)
TR (1) TR200100290T2 (fr)
WO (1) WO2000006130A1 (fr)
ZA (1) ZA200100721B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005047906A (ja) * 2003-07-16 2005-02-24 Taisho Pharmaceut Co Ltd 外用消炎鎮痛剤組成物
KR100689534B1 (ko) * 2005-05-18 2007-03-02 삼성전자주식회사 휴대 단말기

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (fr) * 1987-04-02 1990-06-29 Ciba Geigy Ag
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
WO1995017896A1 (fr) * 1993-12-27 1995-07-06 Akzo Nobel N.V. Preparation pour absorption par voie percutanee
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
ZA200100721B (en) 2002-05-27
AU5284299A (en) 2000-02-21
BR9912688A (pt) 2001-11-27
TR200100290T2 (tr) 2001-07-23
WO2000006130A1 (fr) 2000-02-10
CN1310615A (zh) 2001-08-29
AU762589B2 (en) 2003-06-26
KR20010072071A (ko) 2001-07-31
JP2002521426A (ja) 2002-07-16
IL141032A0 (en) 2002-02-10
DE19834006A1 (de) 2000-02-24
PL345696A1 (en) 2002-01-02
AR019948A1 (es) 2002-03-27
EP1100478A1 (fr) 2001-05-23

Similar Documents

Publication Publication Date Title
CA2338859C (fr) Emplatre contenant de l'estradiol pour l'administration transdermique d'hormones
FI119358B (fi) Estradiolipitoinen laastari
AU696777B2 (en) Triacetin as a transdermal penetration enhancer
EP1737406B2 (fr) Systemes transdermiques contenant des matrices adhesives multicouche pour la modification d'administration de medicaments
CA2160775C (fr) Systeme therapeutique a base d'estradiol pour administration transdermique
EP0921774A1 (fr) Matrice d'administration de medicament transdermique pour la coadministration d'estradiol et d'un autre steroide
CA2465395A1 (fr) Systeme therapeutique transdermique contenant des hormones steroides et du propylene glycol monocaprylate
WO2005060540A2 (fr) Formulations a liberation prolongee de norethindrone et methodes associees a ces formulations
AU762589B2 (en) Estradiol-containing patch for transdermal administration of hormones
MXPA01001042A (en) Estradiol-containing patch for transdermal administration of hormones
KR960013236B1 (ko) 에스트로겐/프로게스틴 경피 전달 장치 및 이를 포함하는 키트
MXPA01001043A (en) Estradiol-containing patch for transdermal administration of hormones
AU2003240942A1 (en) Norethindrone sustained release formulations and methods associated therewith
MXPA97005291A (en) Patch that contains estrad

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20050718